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Genomic organization of ZNF217. (A) The genomic organization of the five exons with encoded initiation and termination codons that 
make up ZNF217. Hatched boxes represent known 59- and 39-untranslated regions (UTR) in the cDNA. The sizes of exons and introns 
appear below and above the map, respectively. (B) The map of the 5632-bp ZNF217 cDNA. Vertical bars represent exon boundaries. 
The relative positions of the predicted eight C2H2 Kruppel-like zinc finger motifs are indicated by white circles. The position of the 
proline-rich putative transcription activator domain is shown as a hatched oval. AUUUA motifs are indicated in the 39-untranslated 
region. The relative locations of three ESTs are shown in boxes. 
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Full-length ZNF217 cDNAs encode two open reading 
frames of 1,062 and 1,108 amino acids, due to 
alternative splicing of exon 4. Each predicted protein 
has eight C2H2 zinc fingers and a proline-rich domain. 
Sequence analysis of ZNF217 indicates a strong 
resemblance to members of the Kruppel-like family of 
zinc finger proteins. The eight zinc finger domains in 
ZNF217 are interspersed throughout the ZNF217 
sequence and their pattern does not appear to fall into 
one of the three classes of C2H2 zinc finger proteins; 
triple-C2H2, multiple-adjacent, and separated-paired 
fingers. The sixth and seventh zinc fingers in ZNF217 
are separated by the conserved linker sequence, 
TGEKP, reported to bind DNA with high affinity. 
Database analysis indicates that this paired zinc finger 
region aligns with those in several members of the 
Delta-EF1/ZFH-1 family of two-handed zinc-finger 
homeodomain proteins, including Smad-Interacting 
Protein 1 (SIP-1). 
Expression 




ZNF217 protein localizes to the nucleus and co-
immunoprecipitates with complexes containing the 
transcriptional corepressors CoREST and CtBP, histone 
deacetylases HDAC1 and HDAC2, and histone 
methyltransferases G9a and Eu-HMTase1. This 
strongly suggests that ZNF217 may function as part of 
a transcriptional repressor complex. 
Implicated in 
The findings that ZNF217 can immortalize human 
mammary epithelial cells, and that its amplification is 
associated with poor prognosis, suggest that it may play  
roles in both early and late stage breast cancer. ZNF217 
can attenuate apoptotic signals resulting from telomere 
dysfunction as well as from doxorubicin-induced DNA 
damage, while silencing ZNF217 with siRNA restores 
sensitivity to doxorubicin. Moreover, elevated ZNF217 
leads to increased phosphorylation of Akt, whereas 
inhibition of the phosphatidylinositol 3 kinase pathway 
and Akt phosphorylation decreases ZNF217 protein 
levels and increases sensitivity to doxorubicin. These 
results suggest that ZNF217 may promote neoplastic 
transformation by increasing cell survival during 
telomeric crisis, and may promote later stages of 
malignancy by increasing cell survival during 
chemotherapy. 
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